This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Syed Hasan Razi Abdi: Innovator in Chiral Resolution Technology
Introduction
Syed Hasan Razi Abdi is a notable inventor based in Bhavnagar, India. He has made significant contributions to the field of chemistry, particularly in the area of chiral resolution. His work focuses on developing innovative solutions that have practical applications in the pharmaceutical industry.
Latest Patents
Abdi holds a patent for an "Organic-inorganic hybrid chiral sorbent and process for the preparation thereof." This invention provides an organic-inorganic hybrid chiral sorbent for the chiral resolution of various racemic compounds, including racemic mandelic acid, 2-phenyl propionic acid, diethyl tartrate, 2,2'-dihydroxy-1,1′-binaphthalene (BINOL), and cyano chromene oxide. The sorbent achieves excellent chiral separation, with an enantiomeric excess of 99% for mandelic acid under medium pressure column chromatography. The optically pure enantiomers produced from this process serve as valuable intermediates in pharmaceutical applications.
Career Highlights
Syed Hasan Razi Abdi is affiliated with the Council of Scientific & Industrial Research, where he continues to advance his research and innovation in the field of chemistry. His work has garnered attention for its potential impact on drug development and the pharmaceutical industry.
Collaborations
Abdi has collaborated with notable colleagues, including Rukhsana Ilyas Kureshy and Noor-ul Hasan Khan. These collaborations have contributed to the advancement of research in chiral resolution technologies.
Conclusion
Syed Hasan Razi Abdi is a prominent inventor whose work in chiral resolution technology has significant implications for the pharmaceutical industry. His innovative approach and dedication to research continue to inspire advancements in this critical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
